Literature DB >> 7514738

Report from working group on in vitro tests for chromosomal aberrations.

S M Galloway1, M J Aardema, M Ishidate, J L Ivett, D J Kirkland, T Morita, P Mosesso, T Sofuni.   

Abstract

The following summary represents a consensus of the working group except where noted. The items discussed are listed in the order in which they appear in the OECD guideline (473) for easy reference. Metabolic activation. S9 from animals induced either with Aroclor 1254 or with the combination of phenobarbital with beta-naphthoflavone is acceptable, and other systems could be used with suitable justification. Exposure concentrations. The upper limit of testing should be 10 mM (or 5 mg/ml where molecular weight is not known or mixtures are being tested), whichever is lower. Where this limit is inappropriate the investigator should give detailed justification of the choice of top concentration. Cytotoxicity should be measured not only in range-finding tests but also concurrently with the assay for chromosomal aberrations. Cytotoxicity should be assessed by measurements of cell growth such as cell counts or confluence estimation. Mitotic index data alone are not a sufficient measure of cytotoxicity, except in the case of blood cultures for which other methods are impractical. Cytotoxicity at the top dose should be greater than 50% of concurrent negative/solvent controls, if this can be achieved without exceeding a concentration limit of 10 mM or 5 mg/ml. There should be at least three concentrations scored for aberrations (each with and without S9), covering a toxicity range down to a concentration giving little or no cytotoxicity. This will usually mean that the concentrations scored will be quite closely spaced. It was not possible to reach a consensus on the issue of solubility limits. The group did not agree on whether (a) solubility rather than cytotoxicity should be the limiting factor, such that only one top dose with evident precipitate should be scored even if toxicity is not observed, or (b) several concentrations with evident precipitate should be scored for aberrations if this were necessary to obtain cytotoxicity. It was agreed that evidence of precipitation should be determined in the final culture medium. Controls. Concurrent positive controls are required but the working group thought it inappropriate to specify the control chemicals or the degree of response that should be obtained, leaving it up to the test laboratory to demonstrate that the system was working adequately based on historical data within the laboratory. It is not necessary to include both negative and solvent controls concurrently with the aberration test; solvent controls alone are acceptable provided that the laboratory has data to demonstrate that there is no effect of the solvent on baseline values. Preparation of cultures.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514738     DOI: 10.1016/0165-1161(94)00012-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  16 in total

1.  In vitro chromosome aberration tests using human dental pulp cells to detect the carcinogenic potential of chemical agents.

Authors:  Takeo W Tsutsui; Tomohiro Inaba; Larry W Fisher; Pamela Gehron Robey; Takeki Tsutsui
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

2.  Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry.

Authors:  Morio Kobayashi; Takeo W Tsutsui; Tomoko Kobayashi; Maki Ohno; Yukari Higo; Tomohiro Inaba; Takeki Tsutsui
Journal:  Odontology       Date:  2011-11-15       Impact factor: 2.634

3.  Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay.

Authors:  Steven M Bryce; Derek T Bernacki; Jeffrey C Bemis; Richard A Spellman; Maria E Engel; Maik Schuler; Elisabeth Lorge; Pekka T Heikkinen; Ulrike Hemmann; Véronique Thybaud; Sabrina Wilde; Nina Queisser; Andreas Sutter; Andreas Zeller; Melanie Guérard; David Kirkland; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2017-04       Impact factor: 3.216

Review 4.  Metabolic toxicity screening using electrochemiluminescence arrays coupled with enzyme-DNA biocolloid reactors and liquid chromatography-mass spectrometry.

Authors:  Eli G Hvastkovs; John B Schenkman; James F Rusling
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2012-04-05       Impact factor: 10.745

5.  Evaluation of Existing QSAR Models and Structural Alerts and Development of New Ensemble Models for Genotoxicity Using a Newly Compiled Experimental Dataset.

Authors:  Prachi Pradeep; Richard Judson; David M DeMarini; Nagalakshmi Keshava; Todd M Martin; Jeffry Dean; Catherine F Gibbons; Anita Simha; Sarah H Warren; Maureen R Gwinn; Grace Patlewicz
Journal:  Comput Toxicol       Date:  2021-05-01

6.  Thiocyclam does not induce structural chromosome aberrations in human lymphocytes in vitro.

Authors:  Serap Celikler; Kamel Saleh; Mohammed A A Sarhan
Journal:  Saudi J Biol Sci       Date:  2010-04-13       Impact factor: 4.219

7.  Assessment using human dental pulp cells of clastogenicity of antiseptics used in dental practice and agents for root canal enlargement and cleaning.

Authors:  Itsuro Hori; Yukari Higo; Maki Ohno; Takeo W Tsutsui; Takeki Tsutsui
Journal:  Odontology       Date:  2007-07-25       Impact factor: 2.634

8.  State-of-the-Art Metabolic Toxicity Screening and Pathway Evaluation.

Authors:  Eli G Hvastkovs; James F Rusling
Journal:  Anal Chem       Date:  2016-04-14       Impact factor: 6.986

Review 9.  Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings.

Authors:  Gyula Mózsik; Tibor Past; Omar M E Abdel Salam; Mónika Kuzma; Pál Perjési
Journal:  Inflammopharmacology       Date:  2009-06-26       Impact factor: 4.473

10.  Assessment of the mutagenic activity of extracts of brazilian propolis in topical pharmaceutical formulations on Mammalian cells in vitro and in vivo.

Authors:  Juliana Marques Senedese; Aline Rafaela Rodrigues; Michelle Andrade Furtado; Viviane Dias Faustino; Andresa A Berretta; Juliana M Marchetti; Denise Crispim Tavares
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.